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ABSTRACT 
Cystic Fibrosis (CF) is a severe inherited disease caused by mutations of the gene 
encoding for a chloride channel termed CFTR. Albeit CF is a multiple-organ disease, 
lung inflammation is the most common cause of morbidity and mortality. CF lung 
pathology is characterized by huge infiltrates of neutrophils (PMNs) into the lung 
lumen and by excessive release of  cytokines and chemokines, in particular IL-8. 
After bacterial infection, sustained mainly by Pseudomonas aeruginosa, this 
inflammatory process is amplified, leading to massive recruitment of PMNs which 
contributes to lung tissue damage. Our goal is gain further insights into the pro-
inflammatory signal transduction that underlies the CF lung inflammation. Here we 
reported that P. aeruginosa-dependent transmembrane signalling pathway in 
bronchial epithelia occurs on the one hand via Toll Like Receptors (TLRs) 
activation, thus by activation of MAPK p38, ERK-1/2, JNK and their downstream 
effectors HSP27, RSK and IKK; on the other hand via ATP release and purinergic 
activation which in turn activates Phospholipase-C beta (PLCB). This enzyme is able 
to induce intracellular calcium signalling, triggering the PKC activation. 
Furthermore, here we reported that many of the MAP kinases involved are able to 
promote activation of several Transcription Factors (TFs), such as CREB, CHOP, 
AP-1 and NF-IL6, beside the well known nuclear factor NF-κB. These TFs bind to 
the proximal promoter region of IL-8 gene causing its expression. Moreover, results 
indicate that PLCB1, PLCB3 and PLCB4 isoforms seem to be redundantly activated 
by P. aeruginosa-dependent ATP release through purinergic receptor binding. 
Concluding, the final aim of this Ph.D program has been deepen the pro-
inflammatory transmembrane signalling in order to provide a panel of molecular 
targets which may support the future development of novel therapies for CF lung 
inflammation. 
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1. INTRODUCTION 
1.1 State of the art of the lung pathology in cystic fibrosis 
Cystic fibrosis (CF) is a lethal inherited disease caused by mutations of a gene 
encoding a chloride channel which belong to the superfamily of ABC transporter 
ATPase, termed Cystic Fibrosis Transmembrane conductance Regulator (CFTR). To 
date, more than 1800 different CFTR gene mutations, divided into five classes, are 
associated to CF illness. The most common CFTR mutation, F508del/F508del, 
results in a misfolded protein that is improperly glycosylated. The homozygous 
F508del CFTR protein is degraded into endosomal vesicles failing to reach the apical 
surface of the epithelium. Other CFTR mutations, such as G551D, form a reduced 
functional channel [Welsh, 2001]. Furthermore, there is a large number of modifier 
genes which should affects the clinical symptoms of the disease. 
Although CF is a multiple-organ disease, affecting pancreas, liver, bowel, sweat 
glands and reproductive organs, the lung pathology is the major cause of morbidity 
and mortality in CF. Even if huge progresses were made in understanding the 
molecular biology and the physiology of the CFTR channel, it remains so far 
unknown why CFTR mutations cause the hyper responsiveness to pulmonary 
inflammation. One hypothesis is that CFTR dysfunction, which leads to lesser 
chloride efflux from epithelia and subsequently excessive sodium reabsorption, 
causes dehydration of  the airway surface liquid (ASL) impairing the mucociliary 
clearance. In this condition, mucus accumulates into lung lumen promoting some 
bacterial and fungal colonization by opportunistic pathogens like Pseudomonas 
aeruginosa, Staphilococcus aureus and Aspergillus fumigatus [Cohen, 2012]. 
However, excessive infiltrates of neutrophils (PMNs) and release of pro-
inflammatory cytokines and chemokines, were found also in broncoalveolar lavage 
fluids from young CF children which did not present any bacterial or fungal infection 
[Bonfield, 1999; Muhlebach, 2004]. These evidences suggest that CFTR dysfunction 
prejudices the innate immune system inducing inflammatory processes in infants 
with CF. In this regard, anti-inflammatory drugs have been proposed in order to 
ameliorate CF pulmonary pathology. Both non-corticosteroid anti-inflammatory 
drugs such as Ibuprofen and steroids such as Beclomethasone have been not 
successful treatments so far.  
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Another hypothesis regard the presence of constitutive activation of the nuclear 
factor κ light-chain enhancer of activated B cells (NF-κB) in airway epithelia 
[Cohen, 2012]. NF-κB plays a key role on Tumor Necrosis Factor alpha (TNFα) and 
IL-8 gene expression. IL-8 is the major chemoattractant for PMNs, and dysregulation 
of NF-κB may reflects the excessive IL-8 releasing observed in CF lung pathology, 
which, at least in part, may explain the excessive accumulation of PMNs and their 
products [Cohen, 2012]. Furthermore, constitutive activation of NF-κB signaling 
results in increased amounts of reactive oxygen species (ROS) which are also 
commonly generated by PMNs which are continuously accumulated in the airway. 
Normally, CFTR maintain the downregulation of NF-κB signaling during oxidative 
stress by controlling the degradation of its inhibitor, IκB-α. Unfortunately, this 
response lacks in the CF lung. Moreover, bacterial infection per se increases the pro-
oxidant balance since airway epithelial cells produce detectable levels of H2O2 in 
response to P. aeruginosa and S.aureus infection (see fig. 1), as shown both in 
human epithelial cells in vitro and in murine lung models in vivo [Moskwa, 2006]. It 
has also been shown that H2O2 released from pulmonary epithelia in response to 
different P. aeruginosa strains is due to the activation of the NADPH oxidase Duox-
1 [Rada, 2010]. ROS such as O2, H2O2 and HOCl have been associated with 
increased secretion of IL-8 and IL-6 from lung epithelia upon P. aeruginosa 
infection, and with defective autophagy and reduced CFTR expression [Bérubé, 
2010; Luciani, 2010]. Epithelial cells may control oxidative damage through the 
production of several antioxidant molecules, such as glutathione (GSH) and 
thiocyanate (SCN−) that are released into the ASL. However, also GSH secretion is 
markedly reduced both in patients with cystic fibrosis and in the cystic fibrosis 
mouse model, due to a protein trafficking defect reported in the epithelial cells (for 
review see Galli, 2012). Thus, deficient epithelia CFTR function results in a 
decreased capability to counteract the oxidative stress which continuously takes 
place in CF lungs (see fig. 2) [Cantin, 1987; Xu, 2009; Galli, 2012].  
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Figure 1 
The adaptation process of inhaled bacteria to the cystic fibrosis lung environment. Inhaled bacteria 
expressing flagella, pili and a type 3 secretion system (T3SS) aggregate within the cystic fibrosis lung, 
producing biofilm. Within the biofilm, bacteria lose flagella, pili and the T3SS, increasing the 
production of alginate, releasing CpG DNA and expressing a diverse range of virulence factors which 
promote the evasion of the host immune system. P. aeruginosa also releases the CFTR inhibitor factor 
(Cif), a protein that inhibits the recycling of CFTR in the host. Furthermore, the lipid A structure of 
the LPS is altered through the addition of palmitate and aminoarabinose (CF LPS), resulting in 
increased antibiotic (Ab) resistance and increased induction of IL-8 production by host cells (from: 
Cohen TS and Prince A. Nat Med 2012; 18:509-1-519). 
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Figure 2 
 
Inflammation: a double-edged sword in CF chronic lung disease. Upon exposure to bacteria, 
respiratory epithelial cells release Reactive Oxygen Species (ROS) as an innate anti-infective 
mechanism, together with several anti-microbial peptides such as human beta defensins (hBD-1/2/4) 
and cathelicidins (LL-37). Recruitment of leukocytes also starts from epithelial cells releasing 
chemokines directed to recruit neutrophils (e.g. IL-8, GRO-α/γ), or recruiting lympho-monocytes (e.g. 
RANTES, IP-10, MIP-1a). Also the major pro-inflammatory cytokines (e.g. IL-1β, IL-6 and TNFa) are 
initially expressed and released by surface epithelial cells of the conductive airways. Different 
undesired effect of the activation of PMNs are schematically represented: [1] Neutrophil 
Extracellular Traps (NETs), a pulsed release of DNA from PMNs, originally directed to immobilise 
bacteria and favour their phagocytosis, produce a worsening of the already reduced muco-ciliary 
clearance in CF airways by increasing the viscosity of the Airway Surface Liquid (ASL), an undesired 
effect amplified by the extensive DNA release dependent on cell death of the short-living PMNs; [2] 
proteases released from the granules of activated PMNs produce tissue damage, increase activation 
of the Epithelial Sodium Channel (ENaC), further reducing ASL hydration and fluidity, [3] cleave the 
CXC Receptor 1 expressed on PMNs, reducing their bacterial killing capacity, and peptides cleaved 
by proteases from CXC Receptor 1 bind to TLR2 and further activate PMN chemotaxis [4] (from: 
Cabrini G et al. 2010; Chem Med Chem 17:4392-4404) 
 
 
 
 
 7
1.2 The CFTR channel 
CFTR is a glycosylated protein that functions as a plasma membrane chloride and 
bicarbonate channel [Anderson, 1991] and modulates salt and water transport across 
epithelial cell membranes of various tissues [Huang, 2004; Li, 2005]. CFTR is 
comprised of two membrane-spanning domains (MSD1 and MSD2), two nucleotide-
binding domains (NBD1 and NBD2) and a regulatory domain (R) [Riordan, 2004] 
(see fig. 3) . CFTR activation requires both ATP binding to the interface between 
NBD1 and NBD2 and PKA mediated phosphorylation of the R domain [Cheng, 
1991; Berger, 2005]. A large number of cellular chaperones and co-chaperones 
participate in regulating the correct folding of CFTR [Kim, 2012]. The deletion of 
the phenylalanine residue at position 508 (F508del) in the NBD1 domain is the most 
common class II mutation in cystic fibrosis (CF) and results in a folding defect of 
F508del CFTR, its retention in the endoplasmic reticulum (ER) and the premature 
degradation by the ubiquitin-proteasome system (UPS). The small amount of 
F508del CFTR that escapes from UPS and reaches the plasma membrane functions 
poorly and is unstable on the plasma membrane with a half-life on the cell surface 
significantly shorter than that of the wild type (wt) protein [Lukacs, 1993; Heda, 
2001]. The consequent F508del CFTR-dependent ionic imbalance and the aberrant  
fluid homeostasis at epithelial surfaces in the lung results in the secretion of thick 
mucus which impairs the mucociliary clearance favoring the bacterial infections, 
inflammation and consequent impairment of lung function [Boucher, 2007]. It has 
been shown that culturing cells at low temperature (27oC) can rescue the trafficking 
defect of F508del CFTR and its expression at the cell surface, although still with 
altered gating of the channel and reduced cell surface density and recycling 
efficiency [Denning, 1992; Cholon, 2007; Jurkuvenaite, 2010]. In addition to low 
temperature culture, chemical compounds such as DMSO [Bebok, 1998], glycerol 
[Sato, 1996] or organic solutes [Zhang, 2003] increase the processing of the core-
glycosylated, endoplasmic reticulum-arrested F508del CFTR into the fully 
glycosylated mature form of CFTR. These findings, together with the evidence that 
restoration of small amounts of functional CFTR protein (20-30% of normal levels) 
[Zhang, 2009] can greatly ameliorate the disease severity, have stimulated a great 
effort to identify membrane permeable small molecule compounds which could 
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either rescue the biosynthetic defect of F508del CFTR thus restoring its folding, 
trafficking and insertion into the plasma membrane (correctors) and/or enhance its 
regulated function once rescued to the surface (potentiators).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3 
A theoretical model of CFTR structure. (A) CFTR primary structure containing two nucleotide-
binding domains (NBD1 and NBD2), two membrane-spanning domains (MSD1 and MSD2), and a 
regulatory region (R domain). Each MSD contains two cytoplasmic loops (CL) that form interfaces 
with the NBDs. (B) Model of CFTR where the domains are coloured as in panel A (adapted from: 
Serohijos A W R et al. PNAS 2008; 105:3256-3261) 
 
 
 
The potentiators, interacting directly with the NBD1 and NBD2 of CFTR [Cai, 
2006], rapidly increase CFTR channel activation by either an ATP-dependent 
[Hwang, 2009] or -independent [Eckford, 2012] mechanism, while the correctors 
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require several hours to rescue the functional expression of CFTR. Most of the 
presently identified potential correctors have been selected by high-throughput 
screening which allows a rapid screening of thousands of small molecules before 
being validated in in vitro culture systems [Verkman, 2006; Verkman, 2009]. Some 
of them have displayed some efficacy in restoring F508del CFTR plasma membrane 
localization and improving chloride transport  [Pedemonte, 2006; Wang, 2006; 
Carlile, 2007]. In particular, VX-809 [Van Goor, 2011], developed by Vertex 
Pharmaceuticals, has resulted to be efficacious in improving F508del CFTR surface 
expression and chloride transport in cultured human bronchial epithelial cells 
isolated from CF patients homozygous for the F508del CFTR mutation and is 
presently considered suitable for advancement into Phase III clinical studies in 
combination with the potentiator VX-770 “Kalydeco” [Van Goor, 2009]. This 
combined administration of a potentiator and a corrector together is required to 
rescue a sufficient functional expression of F508del CFTR at the cell surface as the 
F508del CFTR mutation displays both trafficking and gating defects. The mechanism 
of action of many correctors remains relatively poorly known and studies to better 
understand the structure of the CFTR protein and the conformational destabilization 
of F508del NBD1 are useful to develop new compounds that can bind directly to the 
mutant protein. In this respect, the identification of a number of folding correctors of 
F508del CFTR has been discovered in silico structurebased screening utilizing 
homology models of CFTR [Kalid, 2010]. Correctors may rescue the functional 
expression of F508del CFTR either acting as pharmacological chaperones which 
interact directly with the misfolded F508del CFTR protein favoring its folding and 
trafficking to the cell surface [Loo, 2008; Sampson, 2011; Wang, 2007; Yu, 2011] or 
as proteostasis regulators modulating the activity of a plethora of pathways involved 
in F508del CFTR folding and degradation [Balch, 2011; Hanrahan, 2013; Mu, 2008]. 
However, as F508del CFTR trafficking is inhibited by various quality control 
systems, it is becoming evident that a combination of two different correctors or a 
corrector and a potentiator together might be necessary to achieve a significant 
increase in F508del CFTR functional expression and restore the CF symptoms. In 
this respect, compounds having both corrector and potentiator functions would 
alleviate this need for multiple combined administrations but until now very few 
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compounds have been identified with both corrector and potentiator activities 
[Pedemonte, 2011; Phuan, 2011; Knapp, 2012]. It has been recently demonstrated 
that the psoralen-related compound, 4,6,4’-trimethylangelicin (TMA), strongly 
potentiates the cAMP/PKA-dependent activation of wt CFTR in airway cells. 
Moreover, in the same work it has been demonstrated that TMA significantly inhibits 
the expression of the IL-8 gene in airway cells in which the inflammatory response 
has been challenged with P. aeruginosa, suggest that TMA may represent a 
promising lead compound for the development of a single drug therapy useful for 
overcoming the CF defect [Tamanini, 2011]. 
 
1.3 Inside the lung inflammatory process in cystic fibrosis: the MAP kinases-
mediated pro-inflammatory signal transduction  
As previously discussed, CF lung pathology is also featured by exuberant 
neutrophils (PMNs) infiltration in bronchial lumen and increased levels of pro-
inflammatory cytokines and chemokines expression, in particular Interleukin-8 (IL-
8), and free proteases [Welsh, 2001]. After bacterial colonization, sustained mainly 
by P. aeruginosa in the early phases, and by Burkolderia Cepacia in the advanced 
phases, the pro-inflammatory condition tends to worsen dramatically. Indeed, on the 
bacterial surfaces are present several immunostimulatory pathogen–molecular 
patterns (PAMPs), such as lipopolysaccharide (LPS) and flagella. PAMPs are able to 
bind pattern recognition receptors (PRRs) expressed on the cellular surface of the 
host, inducing multiple signal transduction pathways which finally unleash 
inflammatory responses [Welsh, 2001]. In this regard, Toll-like receptors (TLRs) 
play a significant role as PRRs involved in bacterial recognition. For instance, the 
recognition of flagellin subunits released by P. aeruginosa flagella is mediated by 
TLR5, whereas LPS is known to bind TLR4. TLR4 and TLR5 signal transduction is 
mainly mediated through the adaptor protein myeloid differentiation primary 
response gene-88 (MyD88) which in turn leads to phosphorylation of three Mithogen 
Activated Protein Kinase (MAPK): p38 MAPK, Extracellular signal Regulated 
Kinase 1/2 (ERK1/2) and c-Jun-N-terminal Kinase (JNK) [Cohen, 2012]. However, 
knockdown of MyD88 in cystic fibrosis epithelial cells prevented bacterial-induced 
signaling as expected, but did not inhibit NF-κB signaling to the control non-CF cells 
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level [Cohen, 2012]. This data strengthen the hypothesis of constitutive activation of 
the NF-κB pathway in cystic fibrosis cells. Anyway, other mediators of signal 
transduction are activated downstream ERK1/2 and p38 MAPK, such as mitogen and 
stress-activated kinases (MSK) and 90kDa ribosomal S6 kinases (RSK), which lead 
to activation of transcription factors (TFs) like NF-κB and cAMP response element-
binding protein (CREB) [Pierrat, 1998; Roux, 2004]. Among RSK components, 
RSK1 is the most represented form and its phosphorylation may occur downstream 
of both ERK and 3-phosphoinositide–dependent protein kinase-1 pathways, leading 
to activation of C/EBPβ (also known as NF-IL6), as documented in human 
hepatocytes, and/or to activation of CREB, as reported in human airway epithelial 
cells [Lee, 2006]. Another member of the RSK family, the mitogen- and stress-
activated kinase-2 (MSK2), has been reported to be a substrate of p38α, which is 
able to activate both CREB and AP-1 [Pierrat, 1998]. The p38 effectors include also 
the small heat shock protein 27 (HSP27), which is involved in inflammatory 
processes, together with MK2 kinase, with both activating NF-κB [Gorska, 2007]. 
Additionally, HSP27 has been reported to be recruited in IL-1β– and TNFα–
dependent IL-8 gene transcription in HeLa cells [Alford, 2007]. These 
phosphorylations eventually activate transcription factors (TFs), first of all NF-κB 
[Muselet-Charlier, 2007; Boncoeur, 2008].  Moreover, several in vitro studies using 
human epithelial cystic fibrosis cell lines confirmed increased NF-κB signaling and 
the involvement of several proinflammatory cascades, including activation of Ca2+-
dependent signaling and MAPK-dependent activation of activator protein 1 (AP-1), 
in cystic fibrosis epithelia compared to control epithelia [Fu, 2007]. CF airway 
epithelial cells exposed to proinflammatory stimuli, such as TNFα and IL-1β, 
regulate IL-8 gene transcription through the activation of NF-κB, NF-IL6, AP-1, and 
CHOP [Verhaeghe, 2007; Saadane, 2007; Vij, 2008]. Moreover, CREB has been 
proposed to be a TF involved in IL-8 gene transcription machinery in the U937 
monocytic cell lines exposed to Helicobacter pilori VacA toxin [hisatsune, 2008], 
and it has been shown that CREB collaborates with NF-κB in CXC chemokine 
expression in human respiratory carcinoma cells [Sun, 2008]. Additionally, it has 
been recently observed that CREB and NF-κB synergistically induce IL-6 but not IL-
8 gene expression in astrocytes stimulated with TNFα [Spooren, 2010]. 
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1.4 Inside the lung inflammatory process in cystic fibrosis: the calcium-
dependent signal transduction pathways 
Also extracellular ATP activates cytosolic calcium signaling contributing to the 
expression of pro-inflammatory genes. In this regard, P. aeruginosa has been shown 
to interact with asialo-GM1 receptor (ASGM1R) which co-localizes with TLR5, 
promoting sustained release of nucleotides. The ATP which accumulates within the 
cellular milieu bind the G-coupled seven transmembrane spanning domain purinergic 
receptors (P2Y2) which in turn activate cytosolic calcium signalling, through the 
activation of the enzyme Phospholipase-C (PLC), contributing to IL-8 expression. In 
this regard, PLC-β isoforms are implicated in signal transduction by receptors for 
hormones, growth factors, neurotransmitters and other ligands involved in regulation 
of different cellular processes, including the immune response. It has been shown 
that PLCB3 isoform is selectively coupled to the P2Y2 receptor-activated calcium 
transients in recombinant CHO cells. PLCB3 catalyzes the hydrolysis of 
phosphatidylinositol 4,5-biphosphate (PIP2) to generate 1,2-diacylglicerol (DAG) 
and inositol 1,4,5 triphosphate (IP3). DAG is an activator of protein kinase C (PKC) 
which translocate to the plasmamembrane upon its phosphorylation, whereas IP3 
activate intracellular calcium transients. Notably, it has been recently shown that 
UDP can activate cytosolic calcium rise in murine macrophages through the 
activation of purinergic receptors which in turn activate both PLCB3 and PLCB4, 
whereas other ligands like C5a activate only PLCB3 isoform (25). 
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2.AIMS OF THE DOCTORAL PROJECT 
 
2.1 Aims overview 
The general aim of this doctoral project is to explore the signal transduction 
pathways which regulate the pro-inflammatory gene expression, in particular the 
chemokine IL-8, in respiratory epithelial cells exposed to pro-inflammatory stimuli 
specific of CF lung disease, in order to highlight molecular targets for novel anti-
inflammatory approaches.  
Specific aims can be summarized as follows:  
1. Comprehensive analysis of the molecular mechanisms that underlie the IL-8 
transcription in bronchial epithelial cells derived from patients affected by 
cystic fibrosis. 
2. Investigate the transmembrane calcium-mediated signal transduction during 
P. aeruginosa-dependent pro-inflammatory gene expression. 
 
2.2 Rationale of specific aim 1 
Activation of the transcription machinery of IL-8 could be regulated by the 
intervention of one or more TFs among those reported in different cell models (see 
chapter 1.3), but the precise map of those intervening in cells derived from the 
epithelium lining the conductive airways of bronchi, specifically exposed to P. 
aeruginosa or soluble pro-inflammatory stimuli, is not fully understood. First, we 
scanned the role of TFs with the so-termed TF “decoy” strategy. The aim of the TF 
“decoy” strategy is based on the competition for trans-acting factors between 
endogenous cis-elements present within the regulatory regions of the target gene and 
exogenously added DNA decoys (or functionally active analogues) mimicking the 
specific cis-elements. The objective of this molecular intervention is to cause an 
attenuation of the authentic interactions of trans-factors with their cis-elements, 
leading to a removal of the trans-factors from the endogenous cis-element inside the 
cell (see fig. 4). The most important feature of potential decoy molecules is the 
ability to tightly bind to target transcription factors. In this case, the expression of 
genes directly regulated by the targeted transcription factors will be deeply altered.  
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Figure 4 
The decoy strategy targeting NF-κB. The interactions between decoy oligonucleotides and p50/p65 
heterodimers  inhibit transcription (from: Cabrini G et al. 2010; Chem Med Chem 17:4392-4404). 
 
 
 
With this approach the host laboratory of this doctoral project previously observed 
the novel role of the TF Sp1 in the regulation of expression of IL-6 [Borgatti, 2007] 
and confirmed that of NF-κB for IL-8 in human bronchial epithelial cell lines derived 
from a CF patient [Bezzerri, 2008]. After in silico analysis of the putative consensus 
sequences for binding of TFs in IL-8 promoter, short 18-22 bp 
oligodeoxynucleotides (ODNs) mimicking in part or completely the consensus 
sequences identified, with proper flanking strands to confer resistance to nucleases, 
have been designed, synthesized and transfected in bronchial cells as TF “decoy” 
short molecules as previously described [Borgatti, 2007; Bezzerri, 2008]. In order to 
validate that interaction of TF “decoy” molecules in bronchial epithelial cells is 
actually related to each TF, the Electrophoretic Mobility Shift Assays (EMSA) have 
been performed, as previously described [Bezzerri, 2008]. Short sequence TF 
“decoy” ODNs should provide the possibility of dissecting the different parts of the 
IL-8 promoter and ultimately rebuild a complete scanning of the promoter sequences 
relevant to IL-8 transcription.  
Moreover, it is already known that anti-inflammatory drugs can intervene by 
modulating the function of kinases and adapters upstream the TFs. For instance, 
corticosteroids exert pleiotropic effects by inhibiting cytosolic phospholipase 
A2α through induction of transcription of annexin I and induce MAPK phosphatase 
 15
1, thus inhibiting c-Jun-mediated transcription (for review see Rhen, 2005). 
Therefore the analysis of the effect of P. aeruginosa on the activation of the major 
kinases, either by direct analysis of phosphoproteins, integrated by study of chemical 
inhibitors, could provide an important framework of the intracellular signalling 
leading to IL-8 expression, on which novel potential anti-inflammatory molecules 
can be verified. 
 
2.3 Rationale of specific aim 2 
Chronic airway infection by P. aeruginosa is a common pathological manifestation 
in Cystic Fibrosis (CF) patients [Welsh MJ, 2001]. This manifestation is associated 
with an excessive inflammatory response characterized by the accumulation of large 
amounts of chemokines and cytokines, including IL-8 and IL-1β [Bonfield, 1995]. In 
our specific model, interaction of P. aeruginosa with ASGM1R, colocalized with 
TLR5, is known to promote the release of nucleotides from epithelial cells, activating 
an autocrine loop with P2Y2 receptors [McNamara, 2001; Adamo, 2004], and this is 
at least partly mediated by bacterial flagellin [McNamara, 2006]. Interestingly, some 
PLCB isoforms, such as PLCB3, have been shown to be selectively coupled to the 
P2Y2 receptor-dependent activation of intracellular Ca2+ transients in recombinant 
CHO cells [Strassheim, 2000]. Activation of PLC gamma and epsilon isoforms is 
known to be dependent on tyrosine kinase coupled receptors, whereas the PLC delta 
isoform activation is dependent on the elevation of cytosolic calcium, and only the 
PLC beta isoforms is known to be coupled to seven membrane spanning domain 
receptors, such as purinergic receptors, through GTP binding proteins [Suh, 2008]. 
Also,  among the surface receptors expressed in bronchial epithelial cell that are 
engaged by P. aeruginosa, TLRs and ASGM1R have not been described as coupled 
to GTP binding proteins [Wettschureck, 2005]. Therefore, as human bronchial 
epithelial cells utilized in our experimental model express the transcripts of all the 
PLC beta isoforms, e.g. PLCB1, B2, B3 and B4, albeit at different levels, other 
PLCB isoforms, besides the PLCB3, are the most likely participants in this signaling 
pathway, but their precise role should be completely verified and characterized. 
However, the hydrolysis of phosphatidylinositol 4,5-biphosphate (PIP2) to generate 
two second messengers, diacylglycerol (DAG) and inositol 1,4,5-trisphosphate (IP3), 
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which in turn activate intracellular calcium transients [Katan, 1998; Suh, 2008], as 
mediated by PLC beta isoforms, is a biochemical event which is very upstream the 
intracellular signaling cascade inducing the expression of pro-inflammatory genes. 
Therefore it would be likely that the calcium-associated signaling could result in the 
activation of a differentiated pattern of pro-inflammatory genes in bronchial 
epithelial cells, which could help understanding the relevance and selectivity of 
PLCB isoforms as therapeutic targets in CF lung disease. 
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3. MATERIAL AND METHODS 
 
3.1 Reagents and pharmacological inhibitors 
Human rIL-1β, rTNFα, ATP, Apyrase, pharmaceutical inhibitors KRIBB3, 
parthenolide, and SB203580, have been purchased from Sigma-Aldrich (St. Louis, 
MO). Rabbit polyclonal Ab anti-PLCB3 (sc-13958), goat polyclonal Ab anti-β-actin 
(sc-1615), HRP-conjugated goat anti-rabbit IgG (sc-2004), HRP-conjugated donkey 
anti-goat IgG (sc-2020) and pharmaceutical inhibitors AG1288 and GSK3 inhibitor 
II have been purchased from Santa Cruz Biotechnology (Santa Cruz, CA). SL0101 
and U1026 were from Tocris Bioscience (Ellisville, MO). The calcium chelator 
BAPTA-AM was purchased from Molecular Probes (Eugene, OR), the broad protein 
kinaseC(PKC) inhibitor bisindolylmaleimide- I (BIM-I) was purchased from Merck 
KGaA (Darmstadt, Germany) 
 
3.2 Airway epithelial cell culture 
IB3-1 cells (LGC Promochem Europe) are human bronchial epithelial cells 
immortalized with adeno12/SV40, derived from a CF patient with a mutant 
F508del/W1282X genotype. Cells will be grown in Laboratory of Human 
Carcinogenesis (LHC)-8 basal medium (Biofluids, Rockville, MO) supplemented 
with 5% FBS. All culture flasks and plates will be coated with a solution containing 
35 mg/ml bovine collagen (BD Biosciences, Franklin Lakes, NJ), 1 µg/ml BSA 
(Sigma-Aldrich), and 1 µg/ml human fibronectin (BD Biosciences). CuFi-1 and 
NuLi-1 cells, kindly donated by A. Klingelhutz, P. Karp, and J. Zabner (University 
of Iowa, Iowa City, IA), have been derived from human bronchial epithelia. CuFi-1 
cells have been derived from a patient with CF (CFTR mutant genotype 
F508del/F508del), whereas NuLi-1 cells have been derived from a non-CF subject 
(wild type CFTR), and were transformed by reverse transcriptase component of 
telomerase, hTERT, and human papillomavirus type 16 E6 and E7 gene. These cells 
will be grown on human placental collagen type IV (Sigma-Aldrich)-coated flasks in 
bronchial epithelial growth medium (Cambrex Bioscience, Walkersville, MD). 
Human A549 alveolar type II-derived epithelial cells (American Type Culture 
Collection, Manassas, VA) will be maintained in Dulbecco’s modified Eagle’s 
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medium (DMEM) supplemented with 10% low-endotoxin fetal bovine serum (FBS; 
Bio-Whittaker, Walkersville, MD).  Calu-3 cells were obtained from a human lung 
adenocarcinoma and derived from serous cells of proximal bronchial airways. Calu-3 
cells will be cultured in DMEM containing 4.5 g/l glucose and supplemented with 
10% FBS. MucilAir (Epithelix Sa` rl, Geneva, Switzerland) primary cultures of 
human bronchial epithelial cells have been purchased from are human airway 
epithelia reconstituted in vitro with cells isolated from CF patients or from healthy 
donors,  cultivated on microporous filters at an air–liquid interface (ALI). 
 
3.3 Infection with P. aeruginosa   
The well-characterized motile nonmucoid laboratory strains of P. aeruginosa named 
PAO1, PAK, PAK/∆fl have been kindly donated by A. Prince (Columbia 
University). Bacteria colonies from overnight cultures on trypticase soy agar plates 
(Difco, Detroit, MI) will be grown in 20 ml trypticase soy broth (Difco) at 37°C until 
an OD (A660 nm wavelength), corresponding to 1 × 107 CFU/ml, will be reached. 
Bacteria will be washed twice with PBS and diluted in each specific serum-free 
medium before infection and will be added to cells at the concentration of about  100 
CFU per cell.  
 
3.4 Quantitative RT-PCR 
Total RNA from airway epithelial cells has been purified using High Pure RNA 
Isolation Kit (Roche, Mannheim, Germany), and 2.0 µg RNA has been 
reversetranscribed to cDNA using the High Capacity cDNA Archive Kit and random 
primers (Applied Biosystems, Foster City, CA). For the Real-time qPCR, 50 ng of 
cDNA has been used for each Sybr Green real-time PCR to quantify the relative gene 
expression. The cDNA amplification has been performed for 40 PCR cycles using 
the SYBR Green PCR Master Mix (Applied Biosystems), using 7900HT Fast Real-
Time PCR apparatus (Applied Biosystems, Foster City, CA). In order to perform the 
PCR reaction QuantiTect Primer assays (Qiagen, Hilden, Germany) for IL-8 
(Hs_IL8_1_SG, NM_000584), GROγ (Hs_CXCL3_1_SG, NM_002090), ICAM-1 
(Hs_ICAM1_1_SG, NM_000201), IL-6 (Hs_IL6_1_SG, NM_000600), TNFα 
(Hs_TNF_1_SG, NM_000594), PLCB1 (Hs_PLCB1_1_SG, NM_015192, 
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NM_182734), PLCB3 (Hs_PLCB3_1_SG, NM_000932, NM_001184883), PLCB4 
(Hs_PLCB4_1_SG, NM_000933, NM_001172646, NM_182797),   PLCG2 
(Hs_PLCG2_1_SG, NM_002661),   GAPDH (HS_GAPDH_1_SG, NM_002046) 
and Actin-beta (ACTB) (Hs_ACTB_1_SG, NM_001101) have been used. Changes 
in mRNA expression level have been calculated following normalization with the 
ACTB or GAPDH calibrator genes. Results have been collected with SDS 2.3 
software (Applied Biosystems), and relative quantification has been performed using 
the Ct method. Data have been analyzed with RQ Manager software 1.2 (Applied 
Biosystems). 
 
3.5 Cell transfection with decoy ODNs 
Human bronchial epithelial cells (IB3-1, CuFi-1, or Calu-3) were seeded in 24-well 
plates at a density of 30,000 cells/cm2 and transfected with ODNs using cationic 
liposome vector Lipofectamine 2000 (Invitrogen, Carlsbad, CA) according to the 
manufacturer’s protocol. Lipofectamine 2000 (2 µl) was diluted in 1 ml serum-free 
LHC-8 basal medium (Biofluids) and double-stranded decoy or scrambled ODNs (10 
nM) were added and incubated for 10 min to generate liposome/DNA complexes as 
previously described [Bezzerri, 2008]. Liposome/DNA complexes were then added 
to IB3-1 cells and incubated for 6 h. After this time of incubation cells were washed 
twice with serum-free culture medium and left at 37°C and 5% CO2 for 20–24 h 
before proinflammatory challenge with P. aeruginosa (100 CFU/ ml), IL-1β (10 
ng/ml), or TNFα (50 ng/ml) for a further 4 h. 
 
3.6 Human phospho-MAPK array 
Cells were seeded in 6-cm Petri dishes at a density of 2.5 x 106 cells to obtain 1 x 107 
cells for each array. Cells were starved in LHC-8 basal medium serum-free before 
stimulation with PAO1 (100 CFU/cell), human rIL-1β (10 ng/ml), or human rTNFα 
(50 ng/ml) for 30 min. According to the manufacturer’s protocol, 200 µg cell lysate 
was incubated with each human phospho-MAPK array (R&D Systems, Minneapolis, 
MN). Arrays were exposed to chemoluminescent reagent, and nitrocellulose 
membranes were then exposed to x-ray films. Phospho-MAPK array spot signals 
developed on x-ray films were quantified by scanning the film on a high resolution 
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transmission-mode scanner and analyzing the array image file using the image 
analysis software Digimizer (MedCalc Software, Mariakerke, Belgium). 
 
3.7 Preparation of cell nuclear extracts  
Nuclear extracts were obtained from IB3-1 cells as previously described [Andrews, 
1991]. Briefly, IB3-1 cells were exposed to P. aeruginosa PAO1 strain (100 
CFU/cell), IL-1β (10 ng/ml), or TNFα (50 ng/ml) for 4 h, washed twice with iced 
PBS, and detached by trypsinization. Nuclear proteins were separated by hypotonic 
lysis followed by high-salt extraction treatment of nuclei. Protein concentration was 
determined using the Bradford method. Nuclear extracts were brought to a final 
concentration of 0.5 µg/ml. 
 
3.8 Electrophoretic Mobility Shift Assay  
EMSA experiments were performed as previously described [Borgatti, 2007]. 
Double stranded synthetic ODNs, designed on the putative consensus sequences of 
TFs NF-κB, NF-IL6, AP-1, CHOP, and CREB localized within proximal promoter 
region of the IL-8 gene (see fig. 9), were used. ODNs were labeled with [γ-32P]ATP 
using 10 U T4 polinucleotide kinase (MBI Fermentas, St. Leon-Rot, Germany) in 
500 mM Tris-HCl (pH 7.6), 100 mM MgCl2, 50 mM DTT, and 1 mM EDTA in the 
presence of 50 mCi [g-32P]ATP in a volume of 20 ml for 45 min at 37°C. 
Complementary ODNs (150 ng) were added in 150 mM NaCl buffer for annealing 
reaction, performed at 100°C for 5 min before being left diminish to room 
temperature overnight. Nuclear extracts (2.5 ng) from IB3-1 cells were used and 
poly(dI: dC) (1 mg/reaction) was also added to abolish nonspecific binding. After 30 
min binding at room temperature, the samples were run at constant voltage (200 V) 
under low ionic strength conditions (0.253 TBE buffer:22 mM Tris-borate, 0.4 mM 
EDTA) on 6% polyacrilamide gels. Gels were dried and finally subjected to standard 
autoradiographic procedures. 
 
3.9 PLCB gene silencing 
To perform gene silencing experiments of PLCB isoforms, a TriFECTa RNAi Kit 
(Integrated DNA technologies, Coralville, Iowa, IA) was used accordingly to the 
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manufacturer’s instructions. IB3-1 cells were transiently transfected with specific 
siRNA for PLCB1, (sequence 1, 5’-CGCUAAGAAAUAAUUGAU-3’; sequence 2, 
5’-UGGCUCCAUCAAUUAUUU-3’), PLCB3 (sequence 1, 5’-
AGAUGAGGGACAAGCAUAAGAAGGA- 3’; sequence 2, 5’-
GCUCGAAAGAGGAACCGAAGCAUUUGUUCCU- 3’) PLCB4 (sequence 1, 5’-
AGUAAGGAUAGAAGACUU-3’; sequence 2, 5’-GGAGUAUUACUAGAACAU-
3’) PLCG2 (sequence 1, 5’-GCGCUACAAUAUGGAAAG-3’; sequence 2, 5’-
GGAGAAACAACAUGAAGUA-3’; sequence 3, 5’-
GGACUACCAAGAUCAAGU-3’ or scrambled (sequence, 5’-
CUUCCUCUCUUUCUCUCCCUUGUGA- 3’) duplexes complexed with cationic 
liposomes Lipofectamine 2000 (Invitrogen, Carlsbad, CA). Lipofectamine 2000 (4 
µl) was diluted in 1 ml LHC-8 serum-free cell culture medium. PLCB3 siRNA or 
scrambled duplexes (10 nM) were added and incubated for 10 min. 
Liposome:duplexes complexes in LHC-8 serum-free medium (500 µl) were added to 
IB3-1 cells grown in 2 cm2 wells and incubated at 37°C/5% CO2 for 6 h. Cells were 
washed twice with culture medium and left at 37°C/5% CO2 for an additional 18 h. 
 
3.10 Immunofluorescence 
PLCB3 protein was detected by immunofluorescence. IB3-1 cells were seeded on 8-
well chamber slides (Nunc, Naperville, IL) and preincubated with PLCB3 small-
interfering RNA (siRNA) or scrambled duplexes for 24 h in LHC-8 basal serum-free 
medium as indicated below in the silencing protocol. Cells were washed three times 
with PBS and fixed with 4% paraformaldehyde (w/v) in PBS for 20 min at room 
temperature. After three washes with PBS, cells were permeabilized with methanol at 
220°C for 5 min and dried for 1 h. Slides were incubated with 5% BSA in PBS for 
90 min at room temperature and then subjected to three incubations at room 
temperature with the following: 1) 1/200 dilution of rabbit polyclonal Ab anti-
PLCB3 (sc-13958 from Santa Cruz Biotechnology, Santa Cruz, CA) in 5% BSA for 
1 h or with an irrelevant rabbit IgG Ab; 2) 1/200 dilution of biotinylated goat anti-
rabbit IgG (Santa Cruz Biotechnology) in 1% BSA/PBS-0.1% Tween 20; and 3) 1/60 
dilution of FITC conjugated streptavidin (Sigma-Aldrich) in 1% BSA/PBS-0.1% 
Tween 20. Coverslips were mounted with Prolong Antifade (Molecular Probes) and 
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stored at room temperature. Fluorescence was examined with a digital imaging 
system based on a Zeiss Axiovert 200 fluorescence microscope equipped with a 
back-illuminated charge-coupled device camera (Roper Scientific), excitation, and 
emission filter wheels (Sutter Instruments, Novato, CA) and piezoelectric motoring 
of the z stage (Physik Instrumente, Karlsruhe, Germany) for rapid focusing in the Z 
plane. The data were acquired and processed using the MetaMorph analyzing 
program (Universal Imaging, Downingtown, PA). The Z-steps were then turned into 
projections, and the average intensity after background subtraction was determined. 
All intensity comparisons were determined from at least 10 different cells to 
minimize cell-to-cell staining variations. The levels of PLCB3-silencing were 
expressed as the percentage of arbitrary unit of fluorescence, in respect to scrambled 
condition. 
 
3.11 ELISA 
IL-8 protein release was measured with an ELISA kit. Airway epithelial cells were 
grown and infected as previously described, then supernatants were collected from 
each well, and an ELISA for the quantitative detection of human IL-8 was performed 
using the Human IL-8 Instant ELISA kit (Bender MedSystems, Vienna, Austria), 
according to the manufacturer’s protocol. Briefly, IL-8 present in 100 µl of 
supernatants or standard have been incubated with the antibodies which are adsorbed 
to the microwells furnished by the kit; a biotin-conjugated anti-human IL-8 antibody 
has been incubated to the IL-8 previously captured by the first antibody. 
Subsequently, streptavidin-HRP has been added to the biotin-conjugated anti-human 
IL-8. Following incubation, unbound biotin-conjugated anti-human IL-8 and 
streptavidin-HRP was removed during a wash step, and substrate solution reactive 
with HRP was added to the wells. A coloured product was formed in proportion to 
the amount of soluble human IL-8 present in the sample. The reaction has been 
terminated by addition of acid and absorbance was measured at 450 nm. A standard 
curve was prepared from 7 different human IL-8 standard dilutions and human IL-8 
sample concentration was determined. 
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4. RESULTS 
 
4.1 Pattern of activation of phosphoproteins in bronchial epithelial cells 
infected with  P. aeruginosa 
It has been already defined that surface structures and soluble products from P. 
aeruginosa interact with TLR2/4/5, activating directly a MyD88-dependent cascade 
and leading to the expression of IL-8 and other pro-inflammatory genes in human 
bronchial epithelial cells [Adamo 2004; Chun, 2006]. P. aeruginosa is known to 
activate phosphorylation of MAPKs p38 and ERK1/2, which has been related to IL-8 
gene expression [Ratner, 2001]. MAPK p38 was shown to phosphorylate HSP27, the 
latter leading to activation of IKK and NF-κB, in human colonic epithelial cells upon 
induction by  dextran sodium sulfate [Bhattacharyya, 2009]. Moreover, ERK1/2 
phosphorylates RSK and MSK [Roux, 2004]. RSK has been shown to be activated 
also by phosphorylation of AKT and it has been implicated in the activation of other 
transcription factors relevant to IL-8 gene expression, such as CREB, AP-1, and NF-
IL6 [Roux, 2004]. Another relevant kinase is GSK3, which has been shown to induce 
IL-8 expression in neuroblastoma cells [De Ketelaere, 2004]. As a possible feedback 
mechanism, GSK3 activation can be inhibited through phosphorylation elicited by 
activated AKT [Sugden, 2008]. Thus, we started investigating the potential 
implication of MAPK JNK, RSK, MSK, HSP27, GSK3, and AKT, besides that 
known of MAPK ERK1/2 and p38, in the P. aeruginosa- dependent induction of IL-
8 in the bronchial epithelial IB3-1 cell line. Cells were exposed to the P. aeruginosa 
laboratory strain PAO1 for 30 min, and cell lysates were extracted to detect the 
phosphorylation of these different kinase substrates with a human phospho-MAPK 
array. As far as the MAPK p38 pathway is concerned, a clear phosphorylation of p38 
isoforms α and γ and of the downstream substrate HSP27 can be observed (Fig. 5). 
No striking phosphorylation of the MAPK ERK1/2 was found in P. aeruginosa-
stimulated IB3-1 cells (Fig. 5 A-B), whereas a clear up-regulation of ERK1/2 
phosphorylation levels was observed in stimulated CuFi-1 cells (Fig. 5 C-D). 
However, a clear phosphorylation of RSK1 and MSK2, which are substrates of 
activated ERK1/2, was evident on both bronchial epithelial cell lines (Fig. 5). With 
regard to the ERK1/2-independent kinases known to phosphorylate RSK1/2, we did 
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not observe further phosphorylation of AKT-1/2/3 by P. aeruginosa, whereas total 
phosphorylation of GSK3 was increased (Fig. 5). A significant P. aeruginosa-
stimulated phosphorylation of the MAPK JNK family was observed in CuFi-1 cells 
(Fig. 5 C-D).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FIGURE 5 
Phosphorylation pattern of kinases in bronchial epithelial cells infected with P. aeruginosa. IB3-1 
cells (panels A and B) and CuFi-1 cells (panels C and D) were exposed to P. aeruginosa PAO1 strain 
(100 CFU/cell) for 30 min or medium alone (unstimulated). Cell lysates were collected and analyzed 
using a human phospho-MAPK array as described in the Materials and Methods. A, Spots of the 21 
phospho-kinases quantified with the phospho-MAPK array. B, The intensity of each spot presented in 
A was quantified with Digimizer image analysis software and is represented as a bar graph. The 
numbers indicate the correspondent kinases between A and B,  or between C and D. 
 
 
 25
4.2 Effect of phospho-kinases on IL-8 gene expression in bronchial epithelial 
cells 
In order to test whether the kinases activated by P. aeruginosa are implicated in the 
activation on IL-8 gene transcription, we preincubated three different bronchial 
epithelial cell lines, derived by CF patients (IB3-1 and CuFi-1) or by non-CF 
individuals (Calu-3) with the pharmacological inhibitors of MAPK p38 (SB203580), 
HSP27 (KRIBB3), ERK1/2 (AG1288 and U1026), RSK (SL0101), GSK3 (GSK3-
inh), IKK (parthenolide), and, of JNK (SP600125) before the 4-h infection with P. 
aeruginosa. As shown in Fig. 6, the inhibitors of MAPK p38 and that of its substrate 
HSP27 sharply reduced IL-8 mRNA content, confirming and extending the role of 
this signaling pathway. Similarly, inhibition of ERK1/2 resulted in a significant 
inhibition of P. aeruginosa-dependent IL-8 gene transcription by testing both 
AG1288 and U1026 inhibitors, possibly partly dependent on its downstream kinase 
RSK. IKK inhibition by parthenolide, which in turn inhibits NF-κB activation, 
showed a strong reduction of IL-8 mRNA content (Fig. 6). In summary, the results 
obtained suggest that P. aeruginosa-dependent transmembrane signaling involved in 
IL-8 gene transcription appears associated with MAPK p38 and ERK. However, also 
JNK inhibitors showed inhibitory effect in P. aeruginosa-dependent IL-8 expression 
in CuFi-1 and Calu-3 cells, whereas no effect was observed in IB3-1 cells. 
Interestingly, MAPK p38 downstream effector HSP27 and the ERK substrate RSK1 
seem implicated in this model of inflammation. As previously reported [Saadane, 
2007], IKK was closely related to IL-8 gene expression in CF respiratory epithelial 
cells. The results obtained by mRNA analysis were extended in the CuFi-1 and Calu-
3 human epithelial bronchial cell lines, expressing either F508del-mutated CFTR or 
wild-type CFTR protein, by analyzing the effect of the same inhibitors on the 
expression of IL-8 gene at the protein levels. As shown in Fig 6C and 6E, a 
consensus is evident for the involvement of p38, HSP27, ERK, RSK, and IKK. The 
modest, albeit statistically significant, involvement of GSK3 in IB3-1 cells is not 
consistently confirmed in the other cell lines. 
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Figure 6 
Role of protein kinases in P. aeruginosa-dependent IL-8 gene expression. A, IB3-1 cells were 
preincubated with inhibitors of different kinases before infection with P. aeruginosa PAO1 strain (100 
CFU/ml) for 4 h. SB203580 (10 µM) was added 1 h before infection; KRIBB3 (1 µM) 1 h before 
A 
B 
D 
C 
E 
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infection; AG1288 (200 µM) 2 h before infection; U1026 (10 µM) 1 h before infection; SL0101 (2 
µM) 1 h before infection; SP600125 (3 µM) 1 h before infection; GSK3 inhibitor II (100 nM) 1 h 
before infection; and parthenolide (10 µM) 1 h before infection; total mRNA was extracted from cell 
lysates and quantitative RT-PCR was performed to quantify IL-8 mRNA expression. B and D,   CuFi-1 
and Calu-3 cells, respectively, treated as in A. C and E, IL-8 protein released by CuFi-1 and Calu-3 
cells, respectively, was measured by ELISA and represented as variation relative to basal release of 
IL-8 in starved cellular condition. Data are means ± SEM of three independent experiments 
performed in duplicate and are expressed as percentages of unstimulated cells. *p , 0.05, **p , 0.01 
by Student’s t test. 
 
 
 
4.3 Comparison of MyD88-dependent and -independent signaling pathways 
in IL-8 gene transcription 
 
Because P. aeruginosa activates in parallel both TLR/MyD88-dependent and 
cytosolic calcium-dependent pathways by promoting the release of nucleotides in the 
extracellular milieu, which bind to purinergic P2Y receptors [Chun, 2006; 
McNamara, 2006; Okada, 2013], to further elucidate the role of the MyD88-
dependent cascade in IL-8 gene expression, we stimulated bronchial IB3-1 cells with 
the proinflammatory cytokine IL-1β, which activates MyD88 through its IL-1 
receptor. Through MyD88 adaptor molecule and Toll/IL-1R (TIR) domain, IL-1R 
was shown to activate downstream kinases such as p38 and ERK in HeLa cells, 
finally inducing IL-8 gene expression [Yang, 2008]. Additionally, IL-1β has been 
proposed to activate a sequential ERK/RSK1 cascade both in human nasal epithelial 
cells and in rat vascular smooth muscle cells [Song, 2003; Xu, 2006]. Interestingly, 
HSP27 has been reported to regulate IL-1–dependent IKK activation in HeLa cells 
[Wu, 2009]. To verify and extend these findings in our experimental model, we 
tested the effect of IL-1β–dependent phosphorylation with a human phospho-MAPK 
assay. As shown in Fig. 7A and 7B, IL-1β strongly induced phosphorylation of 
MAPK p38 isoforms α and γ. A modest induction of the isoform δ and no 
phosphorylation of the isoform β were observed (Fig. 7A, 7B). Additionally, an 
increased phosphorylation of HSP27 was detected upon exposure of bronchial cells 
to IL-1β stimulation (Fig. 7A, 7B). Furthermore, enhancement of phosphorylation of 
both ERK2 and its substrates RSK1 and MSK2 was observed. No changes of 
phosphorylation levels of JNK and AKT were detected, whereas a reduction of 
phosphorylation of GSK3β was shown in respect to basal levels (Fig. 7A, 7B).  
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Figure 7 
Phosphorylation pattern of kinases in cells stimulated with IL-1β. IB3-1 cells were exposed to IL-1β 
(10 ng/ml) for 30 min or medium alone (unstimulated). Cell lysates were collected and analyzed using 
the human phospho-MAPK array as described in Materials and Methods. A, Spots of the 21 phospho-
kinases quantified with the phospho-MAPK array. B, The intensity of each spot presented in A was 
quantified with Digimizer image analysis software and is represented as a bar graph. The numbers 
indicate the correspondent kinases between A and B. C, IB3-1 cells were preincubated with inhibitors 
of different kinases before stimulation with IL-1β for 4 h. SB203580 (10 µM) was added 1 h before 
infection; KRIBB3 (1 µM) 1 h before infection; AG1288 (200 µM) 2 h before infection; U1026 (10 
µM) 1 h before infection; SL0101 (2 µM) 1 h before infection; SP600125 (3 µM) 1 h before infection; 
GSK3 inhibitor II (100 nM) 1 h before infection; and parthenolide (10 µM) 1 h before infection; total 
mRNA was extracted from cell lysates, and quantitative RT-PCR was performed to quantify IL-8 
mRNA expression. Data are means ± SEM of three independent experiments performed in duplicate 
and are expressed as percentages of unstimulated cells. *p , 0.05, **p , 0.01,                 ***p , 0.001 
by Student’s t test. 
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Similar to observations obtained with P. aeruginosa-dependent stimulation, 
inhibition of MAPK p38 and HSP27 by SB203580 and KRIBB3, respectively, 
caused a significant reduction of IL-1β–dependent IL-8 gene transcription (Fig. 7C). 
Moreover, pharmacological inhibition of ERK1/2, with both AG1288 and U1026 and 
RSK and JNK, showed a sharp inhibition of IL-8 mRNA content (Fig. 7C). On the 
contrary, GSK3 inhibitor did not reduce IL-8 gene transcription elicited by IL-1β 
(Fig. 7C). Finally, parthenolide strongly inhibited IL-8 gene transcription (Fig. 7C).  
To study a completely MyD88-independent signaling pathway of regulation of IL-8 
gene transcription, we exposed IB3-1 cells to TNFα, which has been reported to 
transduce p38 and JNK signaling through TNFR-associated factor protein activation 
[Hoffmann, 2002; Bouwmeester, 2004]. Additionally, HSP27 has been reported to be 
activated after TNFα stimulation through TAK1 kinase [Alford, 2007]. As shown in 
Fig. 8A and 8B, TNFα induced phosphorylation of MAPK p38 isoform δ but not α, 
β, and γ. Additionally, a 2-fold induction of HSP27 was found (Fig. 8A, 8B). We 
observed phosphorylation of JNK1 and JNK2 phosphokinases (Fig. 8A, 8B). 
Interestingly, TNFα inhibited to different extents the basal phosphorylation of 
several substrates, such as AKT-1 and AKT-3, ERK 1/2, MSK2, and GSK3β. As 
shown in Fig. 8C, pharmacological inhibition of MAPK p38 and HSP27 led to strong 
reduction of TNF-induced IL-8 gene transcription, confirming the role of the p38 
pathway and extending the comprehension of HSP27 activation. Also, inhibition of 
JNK kinases led to a significant decrease of IL-8 mRNA expression, whereas no 
effect was observed using both ERK1/2 inhibitors AG1288 and U1026 and RSK 
inhibitor SL0101 (Fig. 8C). Furthermore, the GSK3 inhibitor partially reduced the 
transcription of IL-8 gene (Fig. 8C). Finally, IKK inhibition by parthenolide showed 
a potent decrease of IL-8 mRNA expression mediated by TNFα (Fig. 8C).  
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Figure 8 
Phosphorylation pattern of kinases in cells stimulated with TNFα. IB3-1 cells were exposed to 
TNFα (50 ng/ml) for 30 min or medium alone (unstimulated). Cell lysates were collected and 
analyzed using a human phospho-MAPK array as described in Materials and Methods. A, Spots of the 
21 phospho-kinases quantified with the phospho-MAPK array. B, The intensity of each spot presented 
in A was quantified with Digimizer image analysis software and is represented as a bar graph. The 
numbers indicate the correspondent kinases between A and B. C, IB3-1 cells were preincubated with 
inhibitors of different kinases before stimulation with TNFα for 4 h. SB203580 (10 µM) was added 1 
h before infection; KRIBB3 (1 µM) 1 h before infection; AG1288 (200 µM) 2 h before infection; 
U1026 (10 µM) 1 h before infection; SL0101 (2 µM) 1 h before infection; SP600125 (3 µM) 1 h 
before infection; GSK3 inhibitor II (100 nM) 1 h before infection; and parthenolide (10 µM) 1 h 
before infection; total mRNA was extracted from cell lysates, and quantitative RT-PCR was performed 
to quantify IL-8 mRNA expression. Data are means ± SEM of three independent experiments 
performed in duplicate and are expressed as percentages of unstimulated cells. *p , 0.05, **p , 0.01,        
***p , 0.001 by Student’s t test. 
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Taken together, the consensus obtained with the results from the three different cell 
lines, expressing either the wild-type or mutated CFTR protein, so far suggests that 
the MyD88/TIR-dependent pathways elicited by P. aeruginosa and IL-1β occur 
through the MAPK p38 isoforms α, δ, and γ, the p38 substrate HSP27, and the 
MAPK ERK2 and its substrate RSK. Additionally, the MyD88-independent TNFα–
induced pathway does not activate ERK1/2, but it does activate MAPK JNK and 
only the isoform d of MAPK p38. 
 
4.4 Development of TF decoy ODNs to interfere with IL-8 gene transcription 
 
Despite the fact that NF-κB and AP-1 are widely established as TFs implicated in the 
expression of IL-8 gene in different cell models [Hoffmann, 2002; Bezzerri, 2008], 
other TFs have been recently reported as possible regulators of IL-8 gene 
transcription, such as the TF CHOP in T-cells and in human bronchial IB3-1 cells 
[Cucinotta, 2008; Vij, 2008], the TF CREB in U937 monocytic cells and in A549 
cells [Hisatsune, 2008; Venza, 2009], and the TF NF-IL6 in human conjunctival and 
bronchial cells induced by P. aeruginosa [Venza, 2009]. To build a comprehensive 
picture of the different TFs intervening in human bronchial epithelial cells 
challenged with P. aeruginosa, we first made an in silico analysis of the proximal 
region of the IL-8 gene promoter (from start site up to 2180 bp) with the TF search 
software TESS (http://www.cbil.upenn.edu/cgi-bin/tess/tess) to obtain a prediction of 
consensus sequences for TFs. The figure 9 summarizes the major TFs which strongly 
and selectively interfere with the transcription of the IL-8 gene in human bronchial 
IB3-1, CuFi-1, Calu-3, and BEAS-2B cell lines. Starting from our previous 
experience and this in silico analysis, decoy ODNs homologous to these sequences 
have been synthesized with the addition of short 5’ and 3’ flanking regions [Bezzerri, 
2008]. In addition to the sequences identified for known TFs, the sequences localized 
between -163/ -128 and -71/-22 bp were termed intermediate sequences A and B 
(ISA and ISB) and tested to evaluate their effects on IL-8 gene transcription. To 
check whether the decoy ODN molecules synthesized are able to interfere with the 
biological activity of TFs NF-κB, NF-IL6, AP-1, CHOP, and CREB, nuclear extracts 
of stimulated cells were produced and preincubated with each TF decoy ODN and 
run by EMSA. As a source of TFs, IB3-1 cells were stimulated with IL-1β, which 
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induces abundant amounts of TFs in the unfractionated nuclear preparation. The 
results shown in Fig. 10 demonstrate that the decoy ODNs completely suppress the 
molecular interactions of these NFs with their specific target sequences. 
Additionally, similar inhibitory activity of the ODN decoys have been obtained, as 
expected, using nuclear extracts prepared from untreated IB3-1 cells, as well as cells 
stimulated with P. aeruginosa or TNFα, in which 95% inhibition of DNA/ protein 
interactions was obtained.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 9 
Proximal region of the promoter of IL-8 gene and putative consensus sequences for TFs. In silico 
study of the proximal region of the IL-8 gene promoter (up to -180 bp from start site) was performed 
using TESS search software to identify the putative consensus sequences for TFs. TESS found 
consensus sequences for TFs CREB, AP-1, NF-IL6, and NF-κB. A previously reported CHOP 
consensus sequence was included (30). ISA, ISB, and TATA box are reported. 
 
 
 
Finally, the inhibitory effects were considered specific, since inhibition of 
DNA/protein interactions were obtained only with each specific ODN decoy 
molecule, with the others being non-active or exhibiting a significantly lower 
activity. This is shown in Fig. 11 (courtesy of Prof. Roberto Gambari and Dr. Monica 
Borgatti, University of Ferrara), which reports the results of a competitive EMSA 
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experiment in which 100 ng cold competitor decoy NF-κB, NF-IL6, AP-1, CHOP, 
and CREB oligonucleotides were incubated for 20 min with nuclear extracts before 
addition of the [32P]-labeled EMSA probes. Fig. 11B clearly shows that NFIL6, AP-
1, CHOP, and CREB double-stranded oligonucleotides do not compete with the NF-
κB probe for binding to nuclear extracts. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 10 
Activation of TFs by proinflammatory challenges and validation of TF decoy ODNs. A, Direct 
binding of [32P]-labeled dsDNA, carrying the target sites for the transcription factors NF-κB, CREB, 
NFIL6, AP-1, and CHOP identified in the IL-8 promoter, to TFs isolated from IB3-1 cells induced 
with IL-1β. [32P]-labeled dsDNA molecules were incubated for 40 min in the presence of 2 µg crude 
nuclear extracts. Protein/DNA complexes were separated by PAGE, and autoradiography was 
performed. B, Effects of dsDNA TF decoy hybrids, carrying the target sites for the transcription 
factors NF-κB, CREB, NF-IL6, AP1, and CHOP identified in the IL-8 promoter, on the interaction 
between NFs and the corresponding [32P]-labeled dsDNA probe. Crude nuclear extracts (2 µg) were 
incubated for 20 min in the presence of 200 ng TF dsDNA molecules, as indicated, and then incubated 
with radiolabeled dsDNA probes for 20 min. Arrow indicates complexes between proteins and target 
molecules, and asterisks indicate the free [32P]-labeled probe (courtesy of Prof. Roberto Gambari and 
Dr. Monica Borgatti, University of Ferrara). 
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As expected, full suppression of the interactions between the [32P]-labeled NF-κB 
probe and nuclear extracts was observed when a cold NF-κB double-stranded ODN 
competitor was employed. Similarly, no cross-competition was observed using [32P]-
labeled CREB (Fig. 11C), NF-IL6 (Fig. 11D), AP-1 (Fig. 11E), and CHOP (Fig. 
11F), with the exception of the CREB oligonucleotide, which to some extent 
competes with AP-1 (but with lower efficiency, as expected; see Fig. 11E). The 
competitive EMSA analysis reported in Fig. 11 does support the concept that the 
decoy approach leads to specific inhibition of TF/DNA interaction; however, these 
results do not formally demonstrate that the decoy molecules interfere with the 
transcription factor activity on the IL-8 promoter in intact cells. Toward this end, 
further chromatin immunoprecipitation (ChIP) experiments need to be performed.  
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Figure 11 
Competitive EMSA assay. EMSA assays were performed using [32P]-labeled NF-κB, CREB, NF-IL6, 
AP-1, and CHOP probes (A–F). Crude nuclear extracts (2 µg) were incubated for 20 min in the 
presence of 200 ng cold NF-κB, CREB, NF-IL6, AP-1, and CHOP competing dsDNA molecules, as 
indicated, and then incubated with [32P]-labeled NF-κB (B), CREB (C), NF-IL6 (D), AP-1 (E), and 
CHOP (F) dsDNA probes for a further 20 min. In B–F, arrows indicate complexes between proteins 
and target molecules, and asterisks indicate the free [32P]-labeled probe. In A, the binding of nuclear 
extracts to [32P]-labeled NF-κB, CREB, NF-IL6, AP-1, and CHOP in the absence of competitors is 
shown (courtesy of Prof. Roberto Gambari and Dr. Monica Borgatti, University of Ferrara). 
 
 
 
 
 36
4.5 Effect of TF decoy ODNs on IL-8 expression in differentially stimulated 
bronchial epithelial cells  
IB3-1 cells were transfected with IL-8 NF-κB, IL-8 NF-IL6, IL-8 AP-1, IL-8 CHOP, 
IL-8 CREB decoy ODNs, ISA and ISB ODNs, or scrambled ODN, each complexed 
with cationic liposomes for 24 h before exposure to P. aeruginosa, IL-1β, or TNFα 
for further 4 hours. As shown in Fig. 12, P. aeruginosa-dependent IL-8 transcription 
in bronchial epithelial cells was significantly inhibited using decoy ODNs against the 
TFs NF-κB, AP-1, CHOP, and CREB, whereas NF-IL6 decoy ODN showed no 
inhibitory activity in IB3-1 cells. Instead, IL-8 gene transcription upon exposure to 
IL-1β was diminished after pre-incubation of decoy ODNs interfering with TFs NF-
κB, NF-IL6, AP-1, CHOP, and CREB. Third, TNFα–mediated IL-8 gene 
transcription was reduced only by pre-incubation of decoy ODNs against NF-κB, 
NFIL6, and AP-1. These results overall suggest a differential interference of TF 
decoy ODNs depending on the pro-inflammatory stimulus in that the TNFα 
pathways seem independent of the participation of the TFs CHOP and CREB. 
Focusing again on P. aeruginosa, we previously demonstrated the strong inhibitory 
effect of TF NF-κB decoy ODNs on the expression of IL-8 gene in CuFi-1 and Calu-
3 cells [Bezzerri, 2008]. In this study, we extended the analysis on the effect of the 
TF decoy ODNs against NF-IL6, AP-1, CHOP, and CREB. As shown in Fig. 13, all 
of these TF decoy ODNs significantly inhibited IL-8 gene transcription and protein 
secretion in CuFi-1 and Calu-3 cells. Finally, no effect on IL-8 gene transcription 
was observed by preincubating ISA and ISB ODNs before stimulation with P. 
aeruginosa, IL-1β, or TNFα. The lack of inhibition of IL-8 transcription always 
observed with ISA and ISB ODNs, based on the sequence localized from -163 to -
138 and from -71 to -22 bases from the transcription start site of the IL-8 gene 
promoter, suggests the absence of putative regulatory elements, as anticipated with in 
silico TESS analyses, in these intervening sequences. Collectively, the results 
presented in this study suggest that the induction of IL-8 gene transcription by P. 
aeruginosa in our human bronchial epithelial cell models is associated with the 
activation of the TFs NF-κB, NF-IL6, AP-1, CHOP, and CREB.  
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Figure 12 
Effect of TF decoy ODNs on IL-8 gene transcription induced by P. aeruginosa, IL-1β, and TNFα 
in IB3-1 bronchial epithelial cells. IB3-1 cells were transfected from 24 h before infection with TF 
decoy ODNs against NFkB (A), NF-IL6 (B), AP-1 (C), CHOP (D), CREB (E), or with sequences ISA 
(F) and ISB (G), all complexed with Lipofectamine 2000. After this pre-incubation period, cells were 
challenged with P. aeruginosa (PAO1, 100 CFU/cell), IL-1β (10 ng/ml), and TNFα (50 ng/ml) for a 
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further 4 h and IL-8 gene expression was measured by quantitative RT-PCR. Results are indicated as 
percentage of transcription obtained by transfection with scrambled ODN. Data shown are means (± 
SEM) of three independent experiments performed in duplicate. *p< 0.05, **p < 0.01, ***p < 0.001 
by Student’s t test. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 13 
Effect of TF decoy ODNs on IL-8 gene expression induced by P. aeruginosa in CuFi-1 and Calu-3 
bronchial epithelial cells. CuFi-1 and Calu-3 cells were transfected from 24 h before infection with 
TF decoy ODNs against NF-κB, NF-IL6, AP-1, CHOP, CREB, or with sequences ISA and ISB 
complexed with Lipofectamine 2000. After this preincbation period, cells were challenged with P. 
aeruginosa (PAO1, 100 CFU/cell) for further 4 h and IL-8 gene expression was measured by qRT-
PCR and ELISA assays. IL-8 mRNA expression in CuFi-1 (A) and Calu-3 (C) cells is shown. Results 
are indicated as percentage of transcription obtained by transfection with scrambled ODN. IL-8 
protein release from CuFi-1 (B) and Calu-3 (D) cells, treated as for A and C, is shown. Results are 
indicated as variation relative to basal release of IL-8. Data are means (± SEM) of three independent 
experiments performed in duplicate. *p< 0.05, **p< 0.01, ***p< 0.001 by Student’s t test. 
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4.6 Silencing of PLCB3 gene reduces the expression of IL-8 in bronchial 
epithelial cells exposed to P. aeruginosa and flagellin 
PLCβ isoforms are implicated in signal transduction by receptors for hormones, 
growth factors, neurotransmitters and other ligands involved in regulation of 
different cellular processes, including the immune response. Although human 
bronchial epithelial cells express, albeit at different levels, the transcripts of all the 
PLCβ isoforms, we focused our attention on PLCB3, because it is the most highly 
expressed within the β isoforms (see fig. 14).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 14 
Comparison of PLCB gene isoforms expression in different bronchial epithelial cells. CF bronchial 
epithelial cells lines IB3-1 and CuFi-1, primary bronchial epithelial cells derived from a CF patient 
(CFBE) and non CF cell line Calu-3 were lysed and total RNA was extracted in order to quantify 
PLCB1, PLCB2, PLCB3 and PLCB4 mRNA expression by qRT-PCR. 
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To understand whether PLCB3 could be relevant in the induction of IL-8 in 
respiratory cells exposed to bacterial infection, we studied the transcription and 
release of IL-8 after silencing the expression of endogenous PLCB3 with siRNA 
oligonucleotides in human bronchial epithelial cells from CF patients exposed to P. 
aeruginosa. Transfection of two different duplexes PLCB3 siRNA reduced 
significantly, albeit partially, the levels of expression of PLCB3 mRNA (Fig. 15A) 
and protein (Fig. 15 panels B–E), as detected by quantitative RT-PCR and confocal 
immunofluorescence, respectively. No significant reduction of transcript levels of 
PLC isozymes β1, β2, and β4 was observed with PLCB3 siRNA in IB3-1 cells. 
Infection with P. aeruginosa did not change significantly the levels of PLCB3 
mRNA. In the same experimental model, partial silencing of PLCB3 produced a 
parallel reduction of IL-8 transcription and release in CF bronchial epithelial IB3-1 
and CuFi-1 cells exposed to P. aeruginosa (Fig. 16 panels A,B and D) without 
changing the basal IL-8 mRNA levels in uninfected cells.  Silencing PLCB3 did 
reduce the IL-8 transcription and release induced by flagellin, a component of P. 
aeruginosa interacting with TLR5, but did not affect the TNFα–dependent IL-8 
expression (Fig. 16 panels C-D), suggesting that PLCB3 may have a role in 
downstream signaling of TLR5 but not TNFRs. The effect of silencing PLCB3 gene 
seems mainly restricted to IL-8, because the expression of other genes induced by P. 
aeruginosa in bronchial epithelial cells, such as ICAM-1, growth-related oncogene 
(GRO) γ, IL-6, and TNFα, is not reduced (Fig. 17). These results provide, to our 
knowledge, the first evidence that PLCB3 could be one of the components of a 
signaling network involved in the expression of IL-8 in human bronchial epithelial 
cells exposed to P. aeruginosa. 
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Figure 15 
Silencing of PLCB3 gene reduces P. aeruginosa-dependent expression and release of IL-8 in 
human bronchial epithelial IB3-1 cells. A, Quantitative expression of PLCB3 mRNA by quantified 
real-time PCR after transfection with PLCB3 siRNA or scrambled oligonucleotides sequences 1 and 2 
for 24 h and subsequent infection with PAO1 (100 CFU/cell) for an additional 4 h. The mRNA 
expression reported in y-axis is relative to scrambled-treated uninfected cells. Mean ±  SEM of eight 
independent experiments performed in duplicate. Immunofluorescence signal of PLCβ3 protein in 
IB3-1 cells transfected with scrambled oligonucleotide sequence 1 (B) or PLCB3 siRNA 
oligonucleotide sequence, in the presence of primary anti-PLCβ3 Ab (C) or irrelevant Ab (D). E, 
Quantification of the fluorescence signal as percentage of fluorescence arbitrary units (F.A.U.) 
related to the expression of PLCβ3 protein of IB3-1 cells treated with scrambled versus PLCB3 siRNA 
oligonucleotides. **p< 0.01, by Student’s t test. 
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Figure 16 
Silencing of PLCB3 gene reduces P. aeruginosa-dependent expression and release of IL-8 in 
human bronchial epithelial IB3-1 cells. A Quantitative expression of IL-8 mRNA after transfection 
with PLCB3 siRNA sequences 1 and 2 or scrambled oligonucleotides in IB3-1 cells. B Quantitative 
expression of IL-8 mRNA after transfection with PLCB3 siRNA sequences 1 and 2 or scrambled 
oligonucleotides in CuFi-1 cells. Mean ± SEM of five independent experiments performed in 
duplicate. C, Effect of PLCB3 siRNA (sequence 1) on IL-8 transcription induced by flagellin (10 
µg/ml) and TNFα (50 ng/ml). Mean ± SEM of three independent experiments performed in duplicate. 
D, Effect of PAO1 (100 CFU/cell), flagellin (10 µg/ml), and TNFα (50 ng/ml) on IL-8 protein release, 
treated as in A with PLCB3 siRNA (sequence 1), or scrambled oligonucleotide. Mean ± SEM of three 
independent experiments performed in duplicate. *p < 0.05, **p < 0.01, ***p < 0.001 by Student’s t 
test. 
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Figure 17 
Pro-inflammatory gene expression in PLCB3 knocked down IB3-1 cells upon exposure to P. 
aeruginosa infection. Effect of PAO1 (100 CFU/cell) in IB3-1 cells transfected with PLCB3 siRNA 
(sequences 1 or 2) on ICAM-1, GROγ, IL-6, and TNFα mRNA transcription. Mean ± SEM of three 
independent experiments performed in duplicate. 
 
 
 
4.7 PLCB3 is implicated in Ca2+-related signaling 
As with the other PLC isoforms, PLCB3 catalyzes the hydrolysis of 
phosphatidylinositol 4,5-biphosphate to generate two second messengers, 1,2-
diacylglycerol (DAG) and inositol 1,4,5-trisphosphate (IP3), which in turn activate 
intracellular calcium transients [Katan, 1998; Suh, 2008]. Notably, it has been 
recently shown that PLCB3 is a critical regulator of intracellular Ca2+ in murine 
macrophages [Roach, 2008]. In collaboration with Prof. Paolo Pinton’s team 
(University of Ferrara),  here we show how the exposure of IB3-1 cells to P. 
aeruginosa induced a sustained increase of cytosolic Ca2+ concentration ([Ca2+ ]c) as 
measured using Fura-2 technique (Fig. 18A). Conversely, buffering the increase of 
[Ca2+]c with the intracellular Ca2+-chelator BAPTA reduced significantly the 
induction of IL-8 mRNA (Fig. 18B), as already reported by other investigators 
[Ratner, 2001; Adamo, 2004]. BAPTA further reduced the IL-8 mRNA expression in 
cells silenced for PLCB3 (Fig. 18C), but in BAPTA-loaded cells PLCB3, gene 
silencing did not reduce IL-8 expression below the level detected in cells treated with 
the control siRNA.  
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Figure 18 
Implication of PLCB3 in P. aeruginosa-dependent calcium signaling. A) Cytosolic free Ca2+ 
concentration as measured with Fura-2/AM assay in IB3-1 cells transfected with scrambled duplex 
and exposed to PAO1 (black trace), or with tissue culture medium alone (blue trace), or after 
transfection of PLCB3 siRNA and a further infection with PAO1 (red trace) (courtesy of Prof. Paolo 
Pinton and Dr. Alessandro Rimessi, University of Ferrara). B) The intracellular Ca2+-chelator 
BAPTA-AM (5 µM) was pre-incubated with IB3- 1 cells for 30 min at 37°C. Cells were exposed to 
PAO1 (100 CFU/cell) or TNFα (50 ng/ml) for a further  4 hrs. C) After pre-incubating IB3-1 cells 
with PLCB3 siRNA or scrambled oligonucleotides for 24 h, BAPTA-AM (5 µM) was added for 30 min 
at 37°C. Infection with PAO1 strain was performed for an additional 4 hrs. Data shown are means (± 
SEM) of three independent experiments performed in duplicate. **p , 0.01, ***p , 0.001 by Student’s t 
test. 
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These findings suggest two set of conclusions. First, that in our experimental model, 
calcium signaling is not completely mediated by PLCB3. Notably, bronchial 
epithelial cells express different PLC isoforms besides the -β3 ones, in particular 
PLCB1 and PLCB4 (Fig. 14). Second, that silencing of PLCB has an effect only 
because it reduces calcium signaling, because in cells in which calcium is chelated 
by BAPTA, no further reduction of IL-8 expression is induced by PLCB3 siRNA. 
The [Ca2+]c increase promoted by P. aeruginosa was reduced in IB3-1 cells 
preincubated with PLCB3 siRNA (Fig. 18A), although not completely, possibly as a 
result of a parallel partial reduction of PLCB3 expression. These results indicate that 
PLCB3 plays a relevant role in triggering free calcium transients induced by P. 
aeruginosa in human bronchial epithelial cells. 
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4.8 Extracellular ATP is not sufficient for IL-8 expression but acts in 
synergy with TLRs 
Interaction of P. aeruginosa with ASGM1R, co-localized with TLR5, is known to 
promote the release of nucleotides from epithelial cells, activating an autocrine loop 
with P2Y2 receptors [McNamara 2001; Adamo, 2004]. Interestingly, PLCB3 has 
been shown to be selectively coupled to the P2Y2 receptor-dependent activation of 
intracellular Ca2+ transients in recombinant CHO cells [Strassheim, 2000]. The role 
of different ligands on the expression of IL-8 has been tested preliminarily. IL-8 
transcription was induced, albeit at different  extents, after exposing IB3-1 cells to 
intact P. aeruginosa bacteria of strains PAO1 and PAK, to the purified P. aeruginosa 
bacterial components flagellin and pilin, and to the proinflammatory cytokine TNFα 
(Fig. 19A). PAK FliC, a recombinant P. aeruginosa PAK strain lacking expression 
of flagellin, induces IL-8 expression at a level lower than that observed with PAK 
(Fig. 19A), suggesting a strong contribution of bacterial flagellum in this signaling 
pathway. On the contrary, no significant induction was obtained with classical 
ligands of TLR4 and purinergic receptor Y2 (P2Y2R), such as LPS and ATP/UTP, 
respectively (Fig. 19A). Because ATP-dependent induction of IL-8 in bronchial 
epithelial cells has been previously described only in association with ligands 
activating TLRs [Fu, 2007], we tested the effect of ATP on the expression of IL-8 
upon stimulation with flagellin, which interacts with TLR5. We observed that ATP is 
not sufficient by itself to induce IL-8 expression, but it is able to potentiate the 
flagellininduced one (Fig. 19B). To verify that P. aeruginosa induces an autocrine 
loop of release of nucleotides, we tested the effect of the ectonucleotidase apyrase in 
our model system. system. 
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Figure 19 
ATP is not sufficient to activate IL-8 mRNA transcription but acts in synergy with TLR-dependent 
signaling. A, IB3-1 cells were exposed to the P. aeruginosa laboratory strains PAO1, PAK, or PAK 
FliC (100 CFU/cell), to flagellin (10 µg/ml) and pilin (10 µg/ml) purified from PAK recombinant 
cells, to LPS (10 µg/ml), to ATP and UTP (1 mM), or to TNFα (50 ng/ml) for 4 h before extraction of 
total RNA and measurement of IL-8 mRNA. B, Similarly to A, IB3-1 cells were exposed to ATP or 
flagellin alone, or to both stimulants together, for 4 h before extraction of total RNA and measurement 
of IL-8 mRNA. Mean ± SEM of three independent experiments performed in duplicate. **p< 0.01, by 
Student’s t test. 
 
 
 
Pre-incubation of IB3-1 cells with apyrase before exposure to P. aeruginosa PAO1 
strain, reduced the sustained increase of [Ca2+]c (Fig. 20 A, kindly provided by Prof. 
Paolo Pinton and Dr. Alessandro Rimessi, University of Ferrara) and, more 
relevantly, the IL-8 mRNA transcription and release of IL-8 protein (Fig. 20 B-C). 
Interestingly, after gene silencing of PLCB3, apyrase does not further reduce the P. 
aeruginosa-dependent IL-8 expression (Fig. 20 D), suggesting that the contribution 
of the purinergic receptor-dependent IL-8 expression is mainly mediated its coupling 
with PLCB3. This confirms a role of extracellular nucleotides, released upon 
interaction of P. aeruginosa with IB3-1 bronchial epithelial cells, in the pro-
inflammatory signaling leading to the expression and secretion of IL-8 in our model. 
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Figure 20 
The ectonucleotidase apyrase affects calcium signaling and IL-8 expression induced by P. 
aeruginosa. A, Cytosolic Ca2+ transients by Fura-2/AM assay in IB3-1 cells exposed to PAO1 treated 
with apyrase (red trace) or solvent alone (untreated, blue trace) - (courtesy of Prof. Paolo Pinton and 
Dr. Alessandro Rimessi, University of Ferrara). B, IB3-1 cells exposed to PAO1 treated with either 
apyrase (3 UI/ml) or solvent alone. C, IL-8 protein was measured by ELISA in IB3-1 cells treated as 
for B. C, Apyrase (3 UI/ml) was incubated for 2 hrs at 37°C after a pre-incubation of 24 hrs with 
PLCB3 siRNA or scrambled oligonucleotides in IB3-1 cells. An additional 4-hrs infection with PAO1 
strain was performed. Data shown are means (± SEM) of four independent experiments performed in 
duplicate. **p< 0.01, ***p< 0.001 by Student’s t test. 
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4.9 Role of PLCB1 and PLCB4 on P. aeruginosa-dependent IL-8 expression 
As it has been shown that P. aeruginosa-mediated calcium signaling is not 
completely mediated by PLCB3 isoform and that PLCB1 and PLCB4 are also 
expressed by bronchial epithelia (Fig. 14) we hypothesized a partial involvement of 
PLCB1 and PLCB4 on P. aeruginosa-dependent IL-8 expression. In order to 
investigate the role of these PLC isoforms in our experimental model, we performed 
several experiments of gene silencing. Transfection of two different siRNA 
molecules reduced significantly, albeit partially, the levels of expression of PLCB1 
and PLCB4 mRNA (Fig. 21 A-B), as detected by quantitative RT-PCR. Silencing of 
PLCB1 and PLCB4 genes did reduce the IL-8 transcription (Fig. 21 C-D) and protein 
release (Fig. 21 E) induced by P. aeruginosa infection. Moreover, simultaneous 
silencing of PLCB1, PLCB3 and PLCB4 further reduced P. aeruginosa-dependent 
IL-8 mRNA expression in IB3-1 cells (Fig. 22A) and CuFi-1 cells (Fig. 22B) upon 
acute infection. Taken together, these data suggest that PLCB1 and PLCB4  may 
have a redundant role together with PLCB3 on pro-inflammatory signal transduction 
in bronchial epithelial cells. In order to check the possible presence of cross-
reactivity among the siRNAs molecules against other PLCB isoforms we measured 
the transcripts levels of each PLCB isoform after each incubation of siRNA 
molecules. No cross-reactivity of siRNAs with unspecific PLCB isoform was 
detected (Fig. 23A-C). 
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Figure 21 
Silencing of PLCB1and PLCB4 genes reduces P. aeruginosa-dependent expression and release of 
IL-8 in human bronchial epithelial cells. Quantitative expression of PLCB1 (A) and PLCB4 (B) 
mRNA by real-time PCR after transfection with PLCB1 and PLCB4 siRNA or scrambled 
oligonucleotides (2 different siRNA sequences) for 24 h in IB3-1 cells and subsequent infection with 
PAO1 (100 CFU/cell) for an additional 4 h. The mRNA expression reported in y-axis is relative to 
scrambled-treated uninfected cells. C, quantitative expression of IL-8 mRNA after transfection with 
PLCB1 siRNA oligonucleotides in IB3-1 cells. D, quantitative expression of IL-8 mRNA after 
transfection with PLCB4 siRNA oligonucleotides in IB3-1 cells. Effect of PAO1 (100 CFU/cell) on   
IL-8 protein release, treated as in A with PLCB1, PLCB3 and PLCB4 siRNA (sequence 1), or 
scrambled oligonucleotides. Mean ±  SEM of four independent experiments performed in duplicate.  
*p < 0.05, **p < 0.01, ***p < 0.001 by Student’s t test. 
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Figure 22 
Comparison of the effect of simultaneous gene silencing of PLCB1, PLCB3 and PLCB4 with 
PLCB3 gene silencing alone, on P. aeruginosa-dependent IL-8 expression in bronchial epithelial 
cells. Quantitative expression of IL-8 mRNA by real-time PCR after transfection with PLCB1, PLCB3 
and PLCB4 siRNA or scrambled oligonucleotides for 24 h in IB3-1 cells (A) or CuFi-1 cells (B). Data 
shown are means (± SEM) of four independent experiments performed in duplicate. *p , 0.05, **p , 
0.01, by Student’s t test. 
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Figure 23 
Check of cross-reactivity of siRNA molecules against PLCB isoforms. Quantitative expression of 
PLCB1 (A) PLCB3 (B) and PLCB4 (C) mRNA by real-time PCR after transfection with PLCB1, 
PLCB3 and PLCB4 siRNA or scrambled oligonucleotides for 24 h in IB3-1 cells. Data shown are 
means (± SEM) of three independent experiments performed in duplicate. 
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4.10 PLCG2 is not involved in P. aeruginosa-depenent IL-8 gene expression 
in bronchial epithelial cells. 
Bronchial epithelial cells do express different isoforms of PLC that could regulate 
intracellular calcium homeostasis and, in particular, IB3-1 and CuFi-1 cells express 
detectable transcript levels of PLCG2, besides PLCB isoforms (Fig. 24). Activation 
of PLC-γ and -ε isoforms is known to be dependent on tyrosine-kinase–coupled 
receptors, of the PLC-δ isoforms on elevation of cytosolic calcium, of the PLC-β 
isoforms on seven-membrane spanning domain receptors through GTP-binding 
proteins [Suh, 2008]. As far as we know, among the surface receptors expressed in 
bronchial epithelial cell that are engaged by P. aeruginosa, TLRs and ASGM1R 
have not been described as coupled to GTP-binding proteins [Wettschureck, 2005]. 
However, it has been previously shown that the interaction of P. aeruginosa with 
bronchial epithelial cells induces the release of ATP in the extracellular milieu, 
which binds to the seven-membrane spanning P2Y2 purinergic receptors 
[McNamara, 2001; Adamo, 2004]. To investigate the role of other PLC isoforms 
which could be activated in our experimental model, we transfected three different 
siRNA molecules against the isoform PLCG2 in bronchial epithelial cells in order to 
silence the PLCG2 gene expression. As shown in figure 25A, two of these three 
siRNA molecules were able to reduce PLCG2 expression in IB3-1 cells. However, 
the PLCG2 gene silencing has not effect on P. aeruginosa-dependent IL-8 
expression (Fig. 25B). These results seems to indicate that the P. aeruginosa-
dependent calcium signal transduction occurs via ATP-P2Y2 pathways which in turn 
elicits PLCB specific activation. 
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Figure 24 
Relative transcript expression levels of PLCγ isoforms in CF bronchial epithelial IB3-1 and CuFi-1 
cell lines. Expression of PLCγ mRNA was quantified by qRT-PCR relative to the levels of expression 
of the housekeeping gene cytokeratin (CK)-15. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 25 
Effect of PLCG2 gene silencing on P. aeruginosa-dependent IL-8 expression. A, quantitative 
expression of PLCG2 mRNA by real-time PCR after transfection with PLCG2 siRNA or scrambled 
oligonucleotides for 24 h in IB3-1 cells. Data shown are means (± SEM) of three independent 
experiments performed in duplicate. B, expression of IL-8 mRNA by real-time PCR in IB3-1 cells 
transfected with PLCG2 siRNA or scrambled oligonucleotides for 24 h and infected with P. 
aeruginosa for further 4 h. **p< 0.01 by Student’s t test. 
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4.11 PLCB3 gene silencing reduces P. aeruginosa-dependent NF-κB 
activation in bronchial epithelial cells. 
 It has been previously shown that P. aeruginosa PAO1 strain activates a Ca2+-
dependent activation of the transcription factor NF-κB, which is critical in the 
regulation of IL-8 gene transcription also in human airway epithelial cells [Ratner, 
2001]. Therefore, we tested the role of PLCB3 on the activation of NF-κB p65 
induced by PAO1 in IB3-1 cells, with a time course preceding the lapse of time of 4 
hours chosen to measure IL-8 mRNA levels. We confirm that PAO1 progressively 
activates NF-κB to translocate into the nucleus of infected IB3-1 cells, and that 
silencing PLCB3 significantly reduces the P. aeruginosa-induced activation of NF-
κB p65 (Fig. 26). However, this assay measured only the total activation of NF-κB 
into the nucleus but did not formerly confirm the increased binding of NF-κB on IL-
8 gene promoter. In order to address this issue, a Chromatin Immuno-precipitation 
(ChIp) need to be planned. Nevertheless, the assay performed indicates a partial role 
of PLCB3 on NF-κB pathway and highlights the potential therapeutic target of 
PLCB3 in CF lung inflammation.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 26 
Effect of PLCB3 gene silencing on P. aeruginosa-dependent NF-κB activation in IB3-1 cells. 
Activation of NF-κB p65 in IB3-1 cells transfected with either PLCB3 siRNA sequence 1 or scrambled 
oligonucleotide for 24 h before exposure to PAO1 (100 CFU/cell) or solvent alone in a lapse of time 
ranging from 1 to 4 h. Absorbance at 450 nm wavelength is proportional to the activation of NF-κB 
p65, as performed with the TransAM NF-κB p65 Activation Assay kit. Data are mean ± SEM of four 
independent experiments performed in duplicate. *p< 0.05 by Student’s t test. 
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5. CONCLUSIONS AND DISCUSSION 
 
Excessive inflammation in the lungs of patients affected by CF is considered a major 
cause of the lung tissue damage leading to respiratory insufficiency. Therefore, a 
thorough understanding of the molecular pathways regulating the chronic lung 
inflammation in CF is highly relevant to design novel approaches to reduce the 
progressive destruction of the pulmonary tissue. As the reported excessive 
recruitment of neutrophils, the chemokine IL-8, is considered a key therapeutic 
target. It is already known that P. aeruginosa, upon interaction with PRRs expressed 
in respiratory epithelial cells, induces a pro-inflammatory signaling involving the 
participation of the MAP kinases p38 and ERK, and of the nuclear transcription 
factors NF-κB, NF-IL6 and AP-1, via MyD88-dependent cascades and intracellular 
calcium [McNamara, 2006; Fu, 2007; Boncoeur, 2008]. In this thesis, these findings 
are basically confirmed and further implication of RSK, GSK3, HSP27, and the 
transcription factors CREB and CHOP are proposed.  
To investigate the signaling cascade of kinases activated by P. aeruginosa, 
here it has been performed a phosphokinase assay. Results confirm that P. 
aeruginosa induces phosphorylation of the MAPK p38 pathway and, specifically, of 
the p38 isoforms alpha, delta and gamma and of their downstream effector HSP27. 
The role of p38 pathway in IL-8 expression is confirmed by the pharmacological 
inhibition of both p38 and HSP27 with SB203580 and KRIBB3, respectively. The 
p38 MAPK and its downstream target, HSP27, were the only kinases which was 
activated by all the three pro-inflammatory challenges (P. aeruginosa, IL-1β and 
TNFα) and here are both reported to partecipate always in IL-8 mRNA expression. It 
has been also observed a direct P. aeruginosa-dependent phosphorylation of ERK1/2 
in CuFi-1 cells, as reported by other investigators [McNamara, 2006], although this 
data seem controversial in IB3-1 cells (Fig. 5). However, results shown a clear 
increase of phosphorylation of RSK1 and MSK2, which are substrates of ERK1/2 
and, in parallel, an inhibitory effect of P. aeruginosa-dependent  IL-8 transcription 
with the inhibitors AG1288 (ERK1/2) and SL0101 (RSK) (Fig. 6). All this 
considered, we are in favour of a role of ERK pathway in P. aeruginosa-dependent 
expression of IL-8. The results obtained here with three pro-inflammatory 
challenges, could provide suggestions  on the signaling related to MyD88-dependent 
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cascades involved in the regulation of transcription IL-8.  Both P. aeruginosa and the 
pro-inflammatory cytokine IL-1β are known to transduce intracellular signals 
through a MyD88/TIR-dependent cascade, whereas TNFα utilizes alternative 
pathways [Bouwmeester, 2004]. As expected from a MyD88 activation, both P. 
aeruginosa and IL-1β activate MAPK p38 and ERK (Fig. 7), whereas TNFα 
involves p38 and JNK, but not ERK pathway (Fig. 8). It has been widely reported 
that NF-κB and AP-1 have a key-role in IL-8 mRNA expression induced by pro-
inflammatory stimuli, including P. aeruginosa [Hoffman, 2002; Hisatsune, 2008; 
Sun, 2008; Vij, 2008]. In collaboration with Prof. Roberto Gambari’s team 
(University of Ferrara), we observed that P. aeruginosa and IL-1β promoted 
activation of the TFs NF-κB, NF-IL6, AP-1, CREB and CHOP, as observed by 
EMSA (Fig. 10). However, TF decoy ODNs against TFs NF-κB, NF-IL6, AP-1, 
CREB and CHOP, resulted in inhibition of IL-8 transcription induced by P. 
aeruginosa and IL-1β (Figs. 12-13) . Furthermore, it has been proposed a role for 
CHOP in the activation of transcription of IL-8 induced by IL-1β and PGE2 in the 
same IB3-1 bronchial epithelial cells  [Vij, 2008]. Here we confirm the involvement 
of CHOP after exposure of IB3-1 cells to both IL-1β and P. aeruginosa by TF decoy 
approach (Figs. 12-13). MAPK p38/HSP27 pathway has been related to CHOP 
activation in melanoma cells [Sarkar, 2002]. Consistently to this hypothesis, we also 
observed phosphorylation of MAPK p38 and a very relevant phosphorylation of 
HSP27 after testing those pro-inflammatory stimuli in which CHOP seems involved, 
namely P. aeruginosa and IL-1β (Figs. 6-7).  CREB has been previously related to 
IL-8 transcription in U937 monocytic cells exposed to VacA toxin [Hisatsune, 2008], 
but never in bronchial epithelial cells challenged with P. aeruginosa and IL-1β as 
shown here. As RSK has been reported as a potential activator of CREB [Roux, 
2004] and we showed that RSK1 was phosphorylated after exposure to P. aeruginosa 
and IL-1β, our transcription factor decoy approach seem to confirm the relation 
between the activations of RSK and CREB, in our experimental model. In parallel, 
the lack of inhibition of CREB by TF decoy ODNs in IB3-1 cells stimulated with 
TNFα is consistent with the suppression of CREB activity by TNFα, previously 
reported in a murine Leydig tumor cells [Arai, 2005].  In addition, here we observe 
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the involvement of RSK1 and MSK2 in the MyD88 pathway and of HSP27 in the 
common p38-related pathway.  It is already known that interaction of P. aeruginosa 
with bronchial epithelial cells induces the release of ATP, as danger signal, which in 
turn activates the heterotrimeric G-coupled P2Y purinergic receptor [McNamara, 
2006; Lazarowski, 2009]. Thus, as G-alpha or G-beta/gamma subunits activate 
phospholipase C beta, leading to intracellular calcium mobilization, the beta/gamma 
subunit activates  phosphoinositide-3 kinase (PI3K)/AKT [Santiago-Perez, 2001; 
Lazarowski, 2009]. PLCs have been shown to be implicated in different cellular 
responses, due to their role in intracellular calcium homeostasis (for review see 
Katan, 1998). As far as its role in inflammatory processes is concerned, PLCB3 has 
been investigated in the context of leukocyte chemotaxis [Bach, 2007]. PLC beta2- 
and beta3-dependent rise in intracellular calcium has been shown to regulate T 
lymphocyte chemotaxis [Li, 2000]. Because T lymphocytes infiltrate the bronchial 
walls of CF patients, these early reports established already a possible link between 
PLCB3 and the progression of CF lung disease. Our findings strengthen this notion 
implicating PLCB3 in regulation of IL-8 expression by bronchial epithelial cells and 
hence neutrophil recruitment into the airways. Bronchial epithelial cells do express 
different isoforms of PLC that could regulate intracellular calcium homeostasis and, 
in particular, IB3-1 and CuFi-1 cells express detectable transcript levels of PLC beta 
1, beta 3, beta 4 (Fig. 14) and PLC gamma 2 (Fig 24). It has been previously shown 
that the interaction of P. aeruginosa with bronchial epithelial cells induces the 
release of ATP in the extracellular milieu, which binds to the seven-membrane 
spanning P2Y2 purinergic receptors [Adamo, 2004; McNamara, 2006]. In this thesis, 
silencing experiments reducing cytosolic calcium increase confirm the involvement 
of PLCB3 in the Ca2+ pathway activated by P. aeruginosa (Fig. 18). Thus, these 
results are consistent with the coupling of P2Y2 purinergic receptors with PLCB3, 
which is known to involve Gaq/11 heterotrimeric GTPase protein [Prince, 2006; Fu, 
2007; Lazarowski, 2009]. Because PLC beta 1 and 4 are also able to interact with 
seven-membrane spanning receptors, we can not definitely restrict to PLCB3 the role 
to modulate P. aeruginosa-dependent calcium transients in bronchial epithelial cells. 
Indeed, silencing of both PLCB1 and PLCB4 isoforms reduced the P. aeruginosa-
dependent IL-8 expression (Fig. 21). Moreover, contemporary silencing of PLCB1, 
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PLCB3 and PLCB4 further reduced the P. aeruginosa-mediated IL-8 expression  
compared to the PLCB3 gene silencing alone in our cell models (Fig. 22).  
 However, also the contemporary silencing of PLCB1, PLCB3 and PLCB4 
reduced only partially the P. aeruginosa-dependent expression of IL-8 (Fig. 22).  
This is not surprising at the light of the partial efficiency of PLCB isoforms silencing 
and of the evidence that P. aeruginosa activates the inflammatory response due to its 
capability to interact with multiple receptors, including TLRs and ASGM1Rs 
[Prince, 2006; McNamara, 2006]. Thus the ATP–P2Y2R autocrine loop that 
generates intracellular Ca2+-signaling should be considered only one of the pathways 
regulating IL-8 expression, in parallel with those elicited by TLRs via MyD88-
dependent signals. We observed a significant reduction of IL-8 mRNA expression 
with the intracellular Ca2+ chelator BAPTA (Fig. 18C), whereas direct stimulation of 
IB3-1 cells with P2Y2 ligands, such as ATP or UTP, that are known to stimulate 
directly cytosolic Ca2+ transients, were not sufficient to induce transcription of IL-8 
mRNA (Fig. 19A), as previously observed by other investigators [Fu, 2007]. This 
apparent discrepancy can be explained observing that the addition of ATP to the 
TLR5/2 and ASGM1R ligand flagellin increases IL-8 mRNA expression (Fig. 19B), 
thus suggesting that the intracellular calcium signaling triggered by purinergic 
receptors upon release of ATP, albeit not sufficient by itself to completely activate 
the transcription machinery for IL-8 expression, works in synergy with TLRs-
mediated signalling. As a further evidence that Ca2+ - signaling mediated by PLCB3 
is indeed relevant to regulate IL-8 expression, we observed that silencing of PLCB3 
significantly reduced the activation of the transcription factor NF-κB (Fig. 26), 
which plays a critical role in the induction of IL-8 transcription [Bezzerri, 2008].  
Based on these and previous findings [Adamo, 2004; McNamara, 2006], we 
conclude that in the CF airway tract chronically infected with P. aeruginosa, the 
Ca2+-dependent pathway induced by the release of nucleotides, through binding to 
P2Y2R, activates PLCB1, PLCB3 and PLCB4 amplifying the innate defense 
signalling based upon TLRs and ASGM1R. The cartoon reported in Fig. 27 
summarizes our working hypothesis. 
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Figure 27 
The pro-inflammatory signal transduction within the lung pathology observed in cystic fibrosis. The 
illustration depicts the signaling pathways elicited by TLRs/MyD88  and P2Y2R/PLCB, based on 
previous reports from other investigators and the results presented in this thesis. Binding of P. 
aeruginosa surface components (flagellin, LPS and pilin) with TLR5, TLR4 and TLR2 triggers a 
MyD88-dependent proinflammatory signaling cascade, eventually leading to nuclear translocation of 
NF-κB, which is a critical transcription factor for the expression of IL-8 gene, together with NF-IL6, 
AP-1, CREB and CHOP. TLRs/MyD88 pathway is sufficient to promote transcription of IL-8 gene. 
Besides exerting this direct effect, P. aeruginosa induces the extracellular release of ATP, possibly via 
a cooperative interaction of TLR5, TLR2, and ASGM1R. Extracellular ATP binds to P2Y2R that 
activates PLC-β through the Gαq,11 heterotrimeric GTPase protein. By degrading 
phosphatidylinositol 4,5-biphosphate, PLC-β promotes IP3 release and DAG formation. IP3 triggers 
Ca2+ release from intracellular stores which ultimately cooperate in activation of NF-κB. The 
P2Y2R/PLC-β pathway is not sufficient to induce IL-8 transcription by itself but strongly act in 
synergy with the TLR/MyD88 signaling cascade. 
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In conclusion, the present work widens the horizon of the different steps of activation 
of transcription of IL-8, particularly in bronchial epithelial cells. A thorough 
understanding of the activatory pathways of RSK, GSK3, HSP27 and of the 
transcription factors CHOP and CREB requires further investigation, as well as the 
PLCB-mediated signal transduction, which relevantly regulates the extracellular 
nucleotide-cytosolic Ca2+ signaling axis potentiating the Toll-like Receptors 
signaling cascade. This study revealed novel pharmacological targets which could be 
useful to attenuate the excessive recruitment of neutrophils without completely 
abolishing the inflammatory response observed in cystic fibrosis. 
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